Divalproex sodium and Acarodermatitis - a phase IV clinical study of FDA data

Summary:

Acarodermatitis is reported only by a few people who take Divalproex Sodium.

The phase IV clinical study analyzes which people take Divalproex sodium and have Acarodermatitis. It is created by eHealthMe based on reports of 6,991 people who have side effects while taking Divalproex sodium from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 15, 2022

6,991 people reported to have side effects when taking Divalproex sodium.
Among them, 2 people (0.03%) have Acarodermatitis.

What is Divalproex sodium?

Divalproex sodium has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 7,174 Divalproex sodium users for its effectiveness, alternative drugs and more.

What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 529 drugs and 284 conditions by eHealthMe.

Number of Divalproex sodium and Acarodermatitis reports submitted per year:

Could Divalproex sodium cause Acarodermatitis?

Gender of people who have Acarodermatitis when taking Divalproex sodium *:

female: 0.0 %
male: 100 %

Age of people who have Acarodermatitis when taking Divalproex sodium *:

Common drugs people take besides Divalproex sodium *:

Common side effects people have besides Acarodermatitis *:

Fatigue (feeling of tiredness): 2 people, 100.00%
Speech Disorder: 2 people, 100.00%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 2 people, 100.00%
Body Temperature Fluctuation: 2 people, 100.00%
Unresponsive To Stimuli: 1 person, 50.00%
Alcohol Induced Persisting Dementia: 1 person, 50.00%
Alcohol Withdrawal Syndrome: 1 person, 50.00%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 1 person, 50.00%
Arachnoid Cyst: 1 person, 50.00%
Atrophy (wasting away of a part of the body): 1 person, 50.00%

Common conditions people have *:

Agitation (state of anxiety or nervous excitement): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Divalproex sodium and have Acarodermatitis?

Check whether Acarodermatitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Common Divalproex sodium side effects:

Browse all side effects of Divalproex sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Acarodermatitis treatments and more:

Acarodermatitis (2,176 reports)

COVID vaccines that are related to Acarodermatitis:

Common drugs associated with Acarodermatitis:

Prednisone: 135 reports

All the drugs that are associated with Acarodermatitis:

Acarodermatitis (529 drugs)

All the conditions that are associated with Acarodermatitis:

Acarodermatitis (284 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium (the active ingredients of Divalproex sodium) and Divalproex sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.